HYGROTON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hygroton, and what generic alternatives are available?
Hygroton is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in HYGROTON is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hygroton
A generic version of HYGROTON was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYGROTON?
- What are the global sales for HYGROTON?
- What is Average Wholesale Price for HYGROTON?
Summary for HYGROTON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,052 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | HYGROTON at DailyMed |
Recent Clinical Trials for HYGROTON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brigham and Women's Hospital | Phase 4 |
| Yuhan Corporation | Phase 1 |
| AHEPA University Hospital | N/A |
US Patents and Regulatory Information for HYGROTON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | HYGROTON | chlorthalidone | TABLET;ORAL | 012283-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | HYGROTON | chlorthalidone | TABLET;ORAL | 012283-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
